Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
Grützmacher P, Öhm B, Szymczak S, Dorbath C, Brzoska M, Kleinert C.
Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):22-26. doi: 10.1007/s11789-017-0090-3.
Severe hypertriglyceridemia: Existing and emerging therapies.
Malick WA, Do R, Rosenson RS.
Pharmacol Ther. 2023 Nov;251:108544. doi: 10.1016/j.pharmthera.2023.108544. Epub 2023 Oct 15.
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
Santos RD, Ruzza A, Hovingh GK, Wiegman A, Mach F, Kurtz CE, Hamer A, Bridges I, Bartuli A, Bergeron J, Szamosi T, Santra S, Stefanutti C, Descamps OS, Greber-Platzer S, Luirink I, Kastelein JJP, Gaudet D; HAUSER-RCT Investigators.
N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29.
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Falko JM.
Endocr Pract. 2018 Aug;24(8):756-763. doi: 10.4158/EP-2018-0157.
Lipoprotein(a) as a cardiovascular risk factor: current status.
Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel.
Eur Heart J. 2010 Dec;31(23):2844-53. doi: 10.1093/eurheartj/ehq386. Epub 2010 Oct 21.
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
Stroes ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, Arca M, Ballantyne CM, Soran H, Prohaska TA, Xia S, Ginsberg HN, Witztum JL, Tsimikas S; Balance Investigators.
N Engl J Med. 2024 May 16;390(19):1781-1792. doi: 10.1056/NEJMoa2400201. Epub 2024 Apr 7.
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
Nurmohamed NS, Navar AM, Kastelein JJP.
J Am Coll Cardiol. 2021 Mar 30;77(12):1564-1575. doi: 10.1016/j.jacc.2020.11.079.
Cholesterol-Lowering Agents.
Hadjiphilippou S, Ray KK.
Circ Res. 2019 Feb;124(3):354-363. doi: 10.1161/CIRCRESAHA.118.313245.
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
Nissen SE, Wolski K, Balog C, Swerdlow DI, Scrimgeour AC, Rambaran C, Wilson RJ, Boyce M, Ray KK, Cho L, Watts GF, Koren M, Turner T, Stroes ES, Melgaard C, Campion GV.
JAMA. 2022 May 3;327(17):1679-1687. doi: 10.1001/jama.2022.5050.
